Winslow Capital Management
IDXX icon

Winslow Capital Management’s Idexx Laboratories IDXX Stock Holding History

Winslow Capital Management’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-512
Closed -$212K – 69
2024
Q4 		$212K Sell
512
-197
-28% -$86.4K ﹤0.01% 68
2024
Q3 		$358K Sell
709
-706,912
-100% -$343M ﹤0.01% 59
2024
Q2 		$345M Buy
707,621
+143,996
+26% +$72.3M 1.24% 31
2024
Q1 		$304M Sell
563,625
-12,930
-2% -$7.07M 1.15% 32
2023
Q4 		$320M Sell
576,555
-113,318
-16% -$53.2M 1.33% 30
2023
Q3 		$302M Buy
689,873
+137,621
+25% +$68.6M 1.44% 30
2023
Q2 		$277M Buy
552,252
+75,702
+16% +$36.3M 1.25% 30
2023
Q1 		$238M Sell
476,550
-396,534
-45% -$190M 1.22% 34
2022
Q4 		$356M Buy
873,084
+208,387
+31% +$80.9M 1.98% 24
2022
Q3 		$217M Buy
664,697
+142,721
+27% +$52.4M 1.27% 37
2022
Q2 		$183M Buy
521,976
+65,217
+14% +$26.6M 0.98% 43
2022
Q1 		$250M Buy
+456,759
New +$240M 1.08% 41

Other funds holding IDXX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

Winslow Capital Management's IDXX Position: Q1 2025 in Review

Winslow Capital Management sold out of Idexx Laboratories (IDXX) in Q1 2025, closing a stake of 512 shares — an estimated $212K sold.

Winslow Capital Management first reported a position in IDXX in Q1 2022 and held it in 12 quarters. The position peaked at $356M in Q4 2022. 1,142 funds tracked by Wall St. Rank hold IDXX as of Q1 2025.

  • Winslow Capital Management reported no remaining Idexx Laboratories position as of Q1 2025 after selling out during the quarter.
  • Winslow Capital Management sold 512 Idexx Laboratories shares in Q1 2025, an estimated $212K.
  • Winslow Capital Management first reported a position in Idexx Laboratories in Q1 2022 and held it in 12 quarters.
  • Winslow Capital Management's Idexx Laboratories position peaked at $356M in Q4 2022.
  • 1,142 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2025.

Based on Winslow Capital Management's 13F filing for Q1 2025, filed 14 May 2025.